11Counselling, recurrence & ethics

FTWhat a diagnosis adds

A confirmed genetic cause is rarely just a name. It does concrete work for the family and the team across several fronts at once — quantifying risk, shaping prognosis, streamlining the work-up, triggering surveillance, and opening the door to testing relatives.[2014]

FTRecurrence and reproductive counselling

The most immediate value for many families is the recurrence risk for future children, which follows directly from the inheritance pattern (Module 3): 1 in 4 for autosomal recessive, 1 in 2 for dominant, maternal-line for mitochondrial. A precise figure replaces anxious guesswork, and — where families wish — allows informed discussion of reproductive options and the testing of at-risk relatives through cascade screening.

CA diagnosis is not a verdict on a life

Counselling must be handled with cultural humility. Many in the Deaf community do not regard deafness as a defect to be fixed, and a genetic result should be offered as information to empower a family's choices, not as a judgement that a deaf life is a lesser one. The same result that one family uses to pursue early implantation, another may use simply to understand their child — and both uses are legitimate.

CThe predicted poor performer

The sharpest ethical question is created by the chapter's own success. If a spiral-ganglion genotype predicts a poor implant result, and implants are expensive and rationed, should that genotype count against offering the device? The source raises this honestly as a looming debate. The case for caution is strong: the predictions are probabilistic, not deterministic; the genotype-outcome data are still thin; spiral-ganglion loss is a continuum; and even a below-average implant result is often far better than none.[2012]

CCounsel, don't gatekeep

The defensible stance, for now, is to let genotype inform expectations and intensify rehabilitation for a predicted poor performer — not to deny access. Genetics should sharpen the conversation a family has before surgery and the support they receive after it, while the decision to implant remains theirs, made on the whole clinical picture. As the evidence firms up, this balance may be tested; the principle of using prediction to help rather than to ration should hold.

The chapter closes by looking forward — to the day genetics may not just predict the implant's result but begin to replace the need for it: gene therapy and the genomic future (Module 12).